Literature DB >> 8957086

High level expression of the HMGI (Y) gene during embryonic development.

G Chiappetta1, V Avantaggiato, R Visconti, M Fedele, S Battista, F Trapasso, B M Merciai, V Fidanza, V Giancotti, M Santoro, A Simeone, A Fusco.   

Abstract

The HMGI protein family includes three proteins, named HMG-I, HMG-Y and HMGI-C. The first two proteins are coded for by the same gene, HMGI (Y), through an alternative splicing mechanism. Their expression is elevated in neoplastic tissues and cells and this overexpression has a causal role in the process of cellular neoplastic transformation. We demonstrate that the HMGI (Y) gene is expressed at very low levels in normal adult tissues, whereas in embryonic tissues it is expressed at high levels comparable to those detected in neoplastic tissues. Specifically, a very high expression of the HMGI (Y) gene was detected in all embryonic tissues at 8.5 dpc. Then in the following days, even though the gene is expressed essentially in all tissues, an abundant gene expression was restricted to some tissues. These results indicate an important role of the HMGI (Y) gene in development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957086

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  117 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

3.  Hmga1 null mouse embryonic fibroblasts display downregulation of spindle assembly checkpoint gene expression associated to nuclear and karyotypic abnormalities.

Authors:  Giovanna Maria Pierantoni; Andrea Conte; Cinzia Rinaldo; Mara Tornincasa; Raffaele Gerlini; Davide Valente; Antonella Izzo; Alfredo Fusco
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 4.  The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Authors:  Tait H Huso; Linda M S Resar
Journal:  Expert Opin Ther Targets       Date:  2014-03-31       Impact factor: 6.902

5.  Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.

Authors:  Siong-Seng Liau; Stanley W Ashley; Edward E Whang
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

6.  Placental Proteomics Reveal Insights into Fetal Alcohol Spectrum Disorders.

Authors:  Katie L Davis-Anderson; Sebastian Berger; Emilie R Lunde-Young; Vishal D Naik; Heewon Seo; Greg A Johnson; Hanno Steen; Jayanth Ramadoss
Journal:  Alcohol Clin Exp Res       Date:  2017-08-09       Impact factor: 3.455

7.  HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells.

Authors:  Sugiko Watanabe; Yasuaki Ueda; Shin-ichi Akaboshi; Yuko Hino; Yoko Sekita; Mitsuyoshi Nakao
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.

Authors:  Gustavo Baldassarre; Sabrina Battista; Barbara Belletti; Sanjay Thakur; Francesca Pentimalli; Francesco Trapasso; Monica Fedele; Giovanna Pierantoni; Carlo M Croce; Alfredo Fusco
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

9.  7SK small nuclear RNA transcription level down-regulates in human tumors and stem cells.

Authors:  Mozhgan Abasi; Zahra Bazi; Samira Mohammadi-Yeganeh; Masoud Soleimani; Vahid Haghpanah; Nosratollah Zargami; Hossein Ghanbarian
Journal:  Med Oncol       Date:  2016-10-17       Impact factor: 3.064

10.  High-mobility group A1 proteins are overexpressed in human leukaemias.

Authors:  Giovanna Maria Pierantoni; Valter Agosti; Monica Fedele; Heather Bond; Irene Caliendo; Gennaro Chiappetta; Francesco Lo Coco; Fabrizio Pane; Maria Caterina Turco; Giovanni Morrone; Salvatore Venuta; Alfredo Fusco
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.